Skip to main content
Clinical Trials/IRCT201310164113N7
IRCT201310164113N7
Completed
Phase 2

Remifentanil versus Fentanyl for pain control during elective endotracheal intubation for surfactant administration in preterm neonates

Vice Chancellor for Research of Tabriz University of of Medical Sciences0 sites32 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Respiratory distress syndrome of newborn.
Sponsor
Vice Chancellor for Research of Tabriz University of of Medical Sciences
Enrollment
32
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice Chancellor for Research of Tabriz University of of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Preterm newborns with gestational age between 28 to 34 weeks and 6 days from last menstrual period of mother who was born in Alzahra teaching hospital of Tabriz; clinical criteria of respiratory distress (consists of: tachypnea, grunting, inter coastal retraction and increased oxygen requirement) and radio graphic findings of Respiratory Distress Syndrome; need for surfactant treatment by INSURE (Intubate, Surfactant, Extubate) procedure.
  • Exclusion criteria: other causes of respiratory distress in newborns; second or third degree AV heart block; use of fentanyl during 4 hours from delivery; severe asphyxia (APGAR score under 5 at 5th minutes after delivery ); impaired consciousness level; major congenital anomalies; difficult intubation due to facial anomalies; more than three attempts for intubation.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials